Target intelligence / Profile preview

Mycobacterial cell envelope lipids

Molecular classification
Lipid, Glycolipid, Fatty acid, Cell wall component
01

Overview

Mycobacterial cell envelope lipids are a complex and unique set of lipid molecules that constitute the outer membrane, or mycomembrane, of Mycobacteria species, including Mycobacterium tuberculosis (Brennan, 2003, PMID: 14551230). These lipids, most notably mycolic acids, are long-chain fatty acids that provide a dense, waxy barrier, making the bacteria highly resistant to environmental stress, chemical disinfectants, and many common antibiotics (Nikaido, 2003, PMID: 12624055). Beyond their structural role, these lipids act as potent virulence factors that modulate the host's immune response, allowing the pathogen to survive within macrophages (Gilleron et al., 2008, PMID: 18463157). Targeting the biosynthesis of these lipids is a cornerstone of tuberculosis therapy, as seen with drugs like isoniazid and ethionamide which inhibit the enoyl-ACP reductase InhA, a key enzyme in mycolic acid production (Vilchèze & Jacobs, 2007, PMID: 17661707). Disruption of this lipid layer leads to increased cell permeability and bacterial death. Understanding the diversity of these lipids is crucial for developing new diagnostics, such as the detection of lipoarabinomannan (LAM) in urine, and therapeutic strategies against mycobacterial infections (Peter et al., 2012, PMID: 22410214).

Other names
Mycobacterial cell wall lipidsMycomembrane lipidsMycolic acidsMycobacterial glycolipidsLipoarabinomannanTrehalose dimycolate
02

Mechanism of action

Inhibition of mycolic acid biosynthesis (e.g., via InhA inhibition) and disruption of the assembly of the mycobacterial mycomembrane.

03

Biological functions

Permeability barrierVirulenceImmune evasionStructural integrityHost-pathogen interaction
04

Disease associations

InfectionTuberculosisLeprosyNontuberculous mycobacterial infection
05

Safety considerations

HepatotoxicityPeripheral neuropathyDrug resistance (MDR-TB/XDR-TB)Long treatment duration requirements
06

Interacting drugs

Isoniazid

5 more in the full profile.

07

Biomarkers

Lipoarabinomannan (LAM)Mycolic acid methyl esters (MAMEs)Trehalose 6,6-dimycolate

Beyond the preview

Go deeper on Mycobacterial cell envelope lipids.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Mycobacterial cell envelope lipids.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call